Healthcare - Biotechnology - NASDAQ - US
$ 1.29
-3.01 %
$ 68 M
Market Cap
-0.43
P/E
INCOME STATEMENT
0
REVENUE
-170 M
OPERATING INCOME
-161 M
NET INCOME
EFFICIENCY
Earnings Waterfall
ALX Oncology Holdings Inc.
| Revenue | 0 |
| Cost Of Revenue | 836 K |
| Gross Profit | -836 K |
| Operating Expenses | 170 M |
| Operating Income | -170 M |
| Other Expenses | -9.47 M |
| Net Income | -161 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 1.2 | 4.8 | 2.1 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.8 | 1.5 | 0.7 | 1.1 | 4.4 | 1.9 |
| Gross Profit | (0.8) | (1.5) | (0.7) | 0.1 | 0.4 | 0.2 |
| OPERATING INCOME | ||||||
| Operating Expenses | 170.3 | 127.4 | 83.6 | 43.8 | 19.6 | 13.9 |
| Selling, General and Administrative Expenses | 28.5 | 29.0 | 23.4 | 14.8 | 3.3 | 2.6 |
| Research and Development Expenses | 141.8 | 98.4 | 60.2 | 29.0 | 16.3 | 11.3 |
| Operating Income | (170.3) | (127.4) | (83.6) | (43.7) | (19.2) | (13.7) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 1.6 | (4.4) | 13 K | 0.8 | 21 K | 0 |
| Total Other Income | 9.5 | 4.0 | 71 K | (1.8) | 26 K | 2 K |
| Pre-Tax Income | (160.8) | (123.4) | (83.5) | (45.5) | (19.2) | (13.7) |
| NET INCOME | ||||||
| Tax Provision | 0 | 64 K | 21 K | 0.2 | 34 K | 45 K |
| Net Income | (160.8) | (123.5) | (83.5) | (45.7) | (19.2) | (13.7) |
| EPS | 3.74 | 3.03 | 2.07 | 1.15 | 0.53 | 0.63 |